Total and cancer mortality in a cohort of ulcerative colitis and Crohn's disease patients: The Florence inflammatory bowel disease study, 1978–2010

Digestive and Liver Disease

Volumn 48, Issue 10, 2016, Pages 1162-1167

  Caini, Saverio ^a   Bagnoli, Siro ^b   Palli, Domenico ^a   Saieva, Calogero ^a   Ceroti, Marco ^a   Bendinelli, Benedetta ^a   Assedi, Melania ^a   Masala, Giovanna ^a  

^a CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cancer mortality; Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis

Indexed keywords

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; ALZHEIMER DISEASE; ARTICLE; BILE DUCT CANCER; BLADDER CANCER; BRAIN CANCER; BRAIN DEGENERATION; BREAST CANCER; BRONCHUS CANCER; CANCER MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COLITIS; COLON CANCER; CROHN DISEASE; DIABETES MELLITUS; ENTERITIS; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HODGKIN DISEASE; HUMAN; INJURY; INTOXICATION; ISCHEMIC HEART DISEASE; ITALY; LIVER CANCER; LUNG CANCER; LYMPHOSARCOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MORTALITY RISK; PARKINSON DISEASE; PATIENT COUNSELING; PERITONEUM CANCER; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RESPIRATORY TRACT DISEASE; RETICULOSARCOMA; RISK REDUCTION; SEX DIFFERENCE; STANDARDIZED MORTALITY RATIO; STOMACH CANCER; TRACHEA CANCER; ULCERATIVE COLITIS; UROGENITAL TRACT DISEASE; VASCULAR DISEASE; AGED; BRAIN TUMOR; MIDDLE AGED; RECTUM TUMOR; REGISTER; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN NEOPLASMS; CAUSE OF DEATH; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HODGKIN DISEASE; HUMANS; ITALY; MALE; MIDDLE AGED; RECTAL NEOPLASMS; REGISTRIES; RESPIRATORY TRACT DISEASES;

EID: 84995559782     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2016.07.008     Document Type: Article

References (52)

1. [1] Satsangi, J., Silverberg, M.S., Vermeire, S., et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55 (2006), 749–753.
2. [2] Levine, J.S., Burakoff, R., Extraintestinal manifestations of inflammatory bowel disease. Gastroenterology & Hepatology (NY) 7 (2011), 235–241.
3. [3] Lutgens, M.W., van Oijen, M.G., van der Heijden, G.J., et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflammatory Bowel Diseases 19 (2013), 789–799.
4. [4] Singh, S., Nagpal, S.J., Murad, M.H., et al. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology 12 (2014), 210–218.
5. [5] Kotlyar, D.S., Lewis, J.D., Beaugerie, L., et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clinical Gastroenterology and Hepatology, 13, 2015 847–58.e4; quiz e48–50.
6. [6] Wolters, F.L., Russel, M.G., Sijbrandij, J., et al. Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut 55 (2006), 510–518.
7. [7] Canavan, C., Abrams, K.R., Hawthorne, B., et al. Long-term prognosis in Crohn's disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff. Alimentary Pharmacology and Therapeutics 25 (2007), 59–65.
8. [8] Wei, S.C., Lin, M.H., Tung, C.C., et al. A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan. BMC Gastroenterology, 13, 2013, 166.
9. [9] Jussila, A., Virta, L.J., Pukkala, E., et al. Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland. Journal of Crohn's and Colitis 8 (2014), 1088–1096.
10. [10] Ventham, N.T., Kennedy, N.A., Duffy, A., et al. Comparison of mortality following hospitalisation for ulcerative colitis in Scotland between 1998–2000 and 2007–2009. Alimentary Pharmacology and Therapeutics 39 (2014), 1387–1397.
11. [11] Romberg-Camps, M., Kuiper, E., Schouten, L., et al. Mortality in inflammatory bowel disease in the Netherlands 1991–2002: results of a population-based study: the IBD South-Limburg cohort. Inflammatory Bowel Diseases 16 (2010), 1397–1410.
12. [12] Jess, T., Loftus, E.V. Jr., Harmsen, W.S., et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940–2004. Gut 55 (2006), 1248–1254.
13. [13] Selinger, C.P., Andrews, J., Dent, O.F., et al. Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitis. Inflammatory Bowel Diseases 19 (2013), 1880–1888.
14. [14] Hovde, Ø., Kempski-Monstad, I., Småstuen, M.C., et al. Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study. Gut 63 (2014), 771–775.
15. [15] Bewtra, M., Kaiser, L.M., TenHave, T., et al. Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflammatory Bowel Diseases 19 (2013), 599–613.
16. [16] Masala, G., Bagnoli, S., Ceroti, M., et al. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978–2001. Gut 53 (2004), 1309–1313.
17. [17] Trallori, G., Palli, D., Saieva, C., et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978–92). Scandinavian Journal of Gastroenterology 31 (1996), 892–899.
18. [18] Winther, K.V., Jess, T., Langholz, E., et al. Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology 125 (2003), 1576–1582.
19. [19] Höie, O., Schouten, L.J., Wolters, F.L., et al. Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut 56 (2007), 497–503.
20. [20] Manninen, P., Karvonen, A.L., Huhtala, H., et al. Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland. Journal of Crohn's and Colitis 6 (2012), 524–528.
21. [21] Palli, D., Trallori, G., Bagnoli, S., et al. Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 119 (2000), 647–653.
22. [22] Eaden, J.A., Abrams, K.R., Mayberry, J.F., The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001), 526–535.
23. [23] Johnson, W.R., McDermott, F.T., Hughes, E.S., et al. The risk of rectal carcinoma following colectomy in ulcerative colitis. Diseases of the Colon and Rectum 26 (1983), 44–46.
24. [24] Choi, P.M., Zelig, M.P., Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35 (1994), 950–954.
25. [25] Beaugerie, L., Itzkowitz, S.H., Cancers complicating inflammatory bowel disease. New England Journal of Medicine 372 (2015), 1441–1452.
26. [26] Canani, R.B., Costanzo, M.D., Leone, L., et al. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology 17 (2011), 1519–1528.
27. [27] Zhao, L.N., Li, J.Y., Yu, T., et al. 5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysis. PLOS ONE, 9, 2014, e94208.
28. [28] Frieri, G., Pimpo, M.T., Palumbo, G.C., et al. Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment. Alimentary Pharmacology and Therapeutics 13 (1999), 1413–1417.
29. [29] Tedde, A., Laura Putignano, A., Bagnoli, S., et al. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scandinavian Journal of Gastroenterology 43 (2008), 712–718.
30. [30] Di Bona, D., Rizzo, C., Bonaventura, G., et al. Association between interleukin-10 polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Journal of Alzheimer's Disease 29 (2012), 751–759.
31. [31] Walton, M., Alaunyte, I., Do patients living with ulcerative colitis adhere to healthy eating guidelines? A cross-sectional study. British Journal of Nutrition 112 (2014), 1628–1635.
32. [32] Barberger-Gateau, P., Raffaitin, C., Letenneur, L., et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 69 (2007), 1921–1930.
33. [33] Singh, B., Parsaik, A.K., Mielke, M.M., et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. Journal of Alzheimer's Disease 39 (2014), 271–282.
34. [34] Boyko, E.J., Perera, D.R., Koepsell, T.D., et al. Coffee and alcohol use and the risk of ulcerative colitis. American Journal of Gastroenterology 84 (1989), 530–534.
35. [35] Nakamura, Y., Labarthe, D.R., A case-control study of ulcerative colitis with relation to smoking habits and alcohol consumption in Japan. American Journal of Epidemiology 140 (1994), 902–911.
36. [36] García, A.M., Ramón-Bou, N., Porta, M., Isolated and joint effects of tobacco and alcohol consumption on risk of Alzheimer's disease. Journal of Alzheimer's Disease 20 (2010), 577–586.
37. [37] Piazza-Gardner, A.K., Gaffud, T.J., Barry, A.E., The impact of alcohol on Alzheimer's disease: a systematic review. Aging and Mental Health 17 (2013), 133–146.
38. [38] Ma, P., Feng, Y.C., Decreased serum fetuin-A levels and active inflammatory bowel disease. American Journal of the Medical Sciences 348 (2014), 47–51.
39. [39] Smith, E.R., Nilforooshan, R., Weaving, G., et al. Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer's disease. Journal of Alzheimer's Disease 24 (2011), 327–333.
40. [40] Laughlin, G.A., McEvoy, L.K., Barrett-Connor, E., et al. Fetuin-A, a new vascular biomarker of cognitive decline in older adults. Clinical Endocrinology 81 (2014), 134–140.
41. [41] Jess, T., Winther, K.V., Munkholm, P., et al. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology 122 (2002), 1808–1814.
42. [42] Hovde, Ø., Moum, B.A., Epidemiology and clinical course of Crohn's disease: results from observational studies. World Journal of Gastroenterology 18 (2012), 1723–1731.
43. [43] De Bie, C., Ballet, V., Hendriks, N., et al. Smoking behaviour and knowledge of the health effects of smoking in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 42 (2015), 1294–1302.
44. [44] Lunney, P.C., Kariyawasam, V.C., Wang, R.R., et al. Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis. Alimentary Pharmacology and Therapeutics 42 (2015), 61–70.
45. [45] Siegel, C.A., Sands, B.E., Risk factors for colorectal cancer in Crohn's colitis: a case-control study. Inflammatory Bowel Diseases 12 (2006), 491–496.
46. [46] Velayos, F.S., Loftus, E.V. Jr., Jess, T., et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology 130 (2006), 1941–1949.
47. [47] Bastida, G., Beltrán, B., Ulcerative colitis in smokers, non-smokers and ex-smokers. World Journal of Gastroenterology 17 (2011), 2740–2747.
48. [48] Palli, D., Masala, G., Trallori, G., et al. A capture-recapture estimate of inflammatory bowel disease prevalence: the Florence population-based study. Italian Journal of Gastroenterology and Hepatology 30 (1998), 50–53.
49. [49] Rubin, D.T., LoSavio, A., Yadron, N., et al. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clinical Gastroenterology and Hepatology 4 (2006), 1346–1350.
50. [50] van Staa, T.P., Card, T., Logan, R.F., et al. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 54 (2005), 1573–1578.
51. [51] Cosnes, J., Carbonnel, F., Beaugerie, L., et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 110 (1996), 424–431.
52. [52] Breuer-Katschinski, B.D., Holländer, N., Goebell, H., Effect of cigarette smoking on the course of Crohn's disease. European Journal of Gastroenterology and Hepatology 8 (1996), 225–228.